Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.

Harvey PD, Green MF, McGurk SR, Meltzer HY.

Psychopharmacology (Berl). 2003 Sep;169(3-4):404-11. Epub 2003 Feb 18.

PMID:
12590356
2.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
3.

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.

Meltzer HY, McGurk SR.

Schizophr Bull. 1999;25(2):233-55. Review.

PMID:
10416729
4.

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.

Cuesta MJ, Peralta V, Zarzuela A.

Schizophr Res. 2001 Mar 1;48(1):17-28. Review.

PMID:
11278151
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2003;(1):CD001359. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD001359.

PMID:
12535408
7.

Risperidone versus other atypical antipsychotic medication for schizophrenia.

Gilbody SM, Bagnall AM, Duggan L, Tuunainen A.

Cochrane Database Syst Rev. 2000;(3):CD002306. Review.

PMID:
10908551
8.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
9.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2000;(2):CD001359. Review. Update in: Cochrane Database Syst Rev. 2003;(1):CD001359.

PMID:
10796640
10.

Clozapine versus other atypical antipsychotics for schizophrenia.

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633. doi: 10.1002/14651858.CD006633.pub2. Review.

11.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
12.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841

Supplemental Content

Support Center